Corporate Banner
Satellite Banner
Technology Networks Header
Saturday, November 29, 2014
 
Register | Sign in
Home Page > White Papers
  White Papers
Scientific News
Two Drugs are No More Effective Than One to Treat Common Kidney Disease
NIH study finds limited kidney benefit from more rigorous blood pressure treatment.
UT Southwestern Scientists Uncover Mechanism That Controls the Fitness of Cells
Scientists uncover novel looping mechanism that may help explain the aging of cells and how they initiate and transmit disease.
Cancer Researchers Identify Gene Mutations and Process for How Kidney Tumors Develop
Researchers have identified more than 3,000 new mutations by using next generation gene sequencing techniques.
Gene Therapy Provides Safe, Long-Term Relief for Patients with Severe Hemophilia B
Gene therapy pioneered by St. Jude Children’s Research Hospital, University College London and the Royal Free Hospital provides men with hemophilia B reliable relief from the bleeding disorder.
Protein Predicts Response To New Immunotherapy Drug
Trial shows that response to treatment may be predicted by the presence of an immune-suppressing protein in non-cancerous immune cells.
NIAID/GSK Experimental Ebola Vaccine Appears Safe, Prompts Immune Response
Results from NIH Phase 1 clinical trial support accelerated development of candidate vaccine.
Researchers Develop Efficient Method to Produce Nanoporous Metals
New technique to manufacture nanoporous metals is cheap and can be done over many scales.
Turkeys may be Lifesavers
Antibiotic to target staph infections, strep, comes from good bacteria in turkeys.
A Hybrid Vehicle That Delivers DNA
University at Buffalo researchers are developing new technology to improve DNA vaccines. The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.
Big Data Set To Make A Big Difference In Childhood Cancer Treatment
UTS researchers are working with the Kids Research Institute to visualise large quantities of patient data to better diagnose and treat childhood cancer patients.
Scroll Up
Scroll Down

Five Keys to Reducing Time-to-Market
Bookmark and Share
Vetter Pharma International GmbH


For access to this article, enter your email address to instantly recieve a Password Reset link.

Please enter your email address below:

Existing users please Sign In here. Don't have an account? Register Here for free access.

Don't have an account? | Register Here



Vetter Announces Opening of Office to Support Growing Asian Healthcare Market
New Asia Pacific office will support customer relations and the development of new business.
Friday, November 21, 2014
Vetter Announces Personnel Changes in its Development Service Division
Clinical manufacturing services continue to attract new business.
Saturday, October 18, 2014
Vetter Continues to Strengthen its Market Position
Another positive year for the CDMO.
Wednesday, January 15, 2014
Vetter to Construct New Filling Lines to Expand Capacity
Responding to customer demand and company growth.
Thursday, October 10, 2013
Vetter’s New Commercial Filling Line Ready for cGMP Filling
Novel, high-tech line fully validated; first customer project underway.
Monday, April 08, 2013
Vetter’s Newest Facility Successfully Completes FDA Inspection
Center for visual inspection and logistics sets high safety and control standards.
Thursday, March 28, 2013
Vetter’s Newest Facility Successfully Completes FDA Inspection
Center for visual inspection and logistics sets high safety and control standards.
Thursday, March 28, 2013
Vetter Offers Answers for the Future at the Pharma Congress 2013
Experts from the CDMO to discuss the challenges and solutions facing the industry.
Tuesday, February 19, 2013
Vetter Receives “Known Consignor” Approval from Germany's Federal Aviation Office
The CDMO meets new requirements six months ahead of deadline.
Wednesday, December 12, 2012
Vetter Receives Top Prize at the European Outsourcing Awards Ceremony
CDMO clinches an industry Oscar for its innovative high-speed filling line.
Friday, October 12, 2012
Vetter’s Development Service Doubles its Revenues and Grows its Capabilities
Ravensburg development labs add enhanced technologies.
Friday, September 28, 2012
Vetter Prepares for Further Growth
A leading CDMO secures triple-digit million euro credit facility.
Tuesday, May 01, 2012
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv